ALE.C04

· Alentis Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALE.C04, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of ALE.C04 in Patients With Head and Neck Cancer [Phase 1, Phase 2]